aTyr Pharma, Inc. (ATYR)
NASDAQ: ATYR · Real-Time Price · USD
0.5449
+0.0575 (11.80%)
May 29, 2026, 10:39 AM EDT - Market open
aTyr Pharma Market Cap
aTyr Pharma has a market cap or net worth of $53.43 million as of May 29, 2026. Its market cap has decreased by -81.86% in one year.
Market Cap
53.43M
Enterprise Value
-7.02M
1-Year Change
-81.86%
Ranking
Category
Stock Price
$0.54
Market Cap Chart
Since May 7, 2015, aTyr Pharma's market cap has decreased from $337.10M to $53.43M, a decrease of -84.15%. That is a compound annual growth rate of -15.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 28, 2026 | 47.80M | -37.68% |
| Dec 31, 2025 | 76.70M | -74.76% |
| Dec 31, 2024 | 303.90M | 267.92% |
| Dec 29, 2023 | 82.60M | 30.08% |
| Dec 30, 2022 | 63.50M | -69.41% |
| Dec 31, 2021 | 207.60M | 428.24% |
| Dec 31, 2020 | 39.30M | 142.59% |
| Dec 31, 2019 | 16.20M | 8.72% |
| Dec 31, 2018 | 14.90M | -85.70% |
| Dec 29, 2017 | 104.20M | 104.31% |
| Dec 30, 2016 | 51.00M | -78.06% |
| Dec 31, 2015 | 232.50M | -31.03% |
| May 7, 2015 | 337.10M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Metagenomi Therapeutics | 50.82M |
| MiNK Therapeutics | 50.72M |
| Radiopharm Theranostics | 50.58M |
| Actuate Therapeutics | 50.48M |
| Xilio Therapeutics | 49.90M |
| Estrella Immunopharma | 49.49M |
| Quantum BioPharma | 48.80M |
| Plus Therapeutics | 45.56M |